APO-ACEBUTOLOL TABLET

Land: Kanada

Sprache: Englisch

Quelle: Health Canada

Wirkstoff:

ACEBUTOLOL (ACEBUTOLOL HYDROCHLORIDE)

Verfügbar ab:

APOTEX INC

ATC-Code:

C07AB04

INN (Internationale Bezeichnung):

ACEBUTOLOL

Dosierung:

100MG

Darreichungsform:

TABLET

Zusammensetzung:

ACEBUTOLOL (ACEBUTOLOL HYDROCHLORIDE) 100MG

Verabreichungsweg:

ORAL

Einheiten im Paket:

100 & 500 TABLETS

Verschreibungstyp:

Prescription

Therapiebereich:

BETA-ADRENERGIC BLOCKING AGENTS

Produktbesonderheiten:

Active ingredient group (AIG) number: 0131282001; AHFS:

Berechtigungsstatus:

MARKETED

Berechtigungsdatum:

1995-12-31

Fachinformation

_APO-ACEBUTOLOL Product Monograph _
_ _
_ _
_ _
_Page 1 of 34 _
_ _
PRODUCT MONOGRAPH
PR APO-ACEBUTOLOL
ACEBUTOLOL TABLETS (AS ACEBUTOLOL HYDROCHLORIDE)
APOTEX STANDARD
100 MG, 200 MG AND 400 MG TABLETS
ANTIHYPERTENSIVE AND ANTI-ANGINAL AGENT
APOTEX INC.
DATE OF REVISION:
150 SIGNET DRIVE
OCTOBER 24, 2018
TORONTO, ONTARIO
M9L 1T9
CONTROL NUMBER# 220342
_APO-ACEBUTOLOL Product Monograph _
_ _
_ _
_ _
_Page 2 of 34 _
_ _
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
..................................................................................................
3
SUMMARY PRODUCT INFORMATION
...................................................................................................................
3
INDICATIONS AND CLINICAL USE
.........................................................................................................................
3
CONTRAINDICATIONS
..............................................................................................................................................
4
WARNINGS AND PRECAUTIONS
............................................................................................................................
4
ADVERSE REACTIONS
..............................................................................................................................................
9
DRUG INTERACTIONS
.............................................................................................................................................
11
DOSAGE AND ADMINISTRATION
.........................................................................................................................
15
OVERDOSAGE
...........................................................................................................................................................
16
ACTION AND CLINICAL PHARMACOLOGY
.......................................................................................................
17
STORAGE AND STABILITY
...........................................